The Lands cycle modulates plasma membrane lipid organization and insulin sensitivity in skeletal muscle
Ferrara, P. J.; Rong, X.; Maschek, J. A.; Verkerke, A. R.; Siripoksup, P.; Song, H.; Krishnan, K. C.; Johnson, J. M.; Turk, J.; Houmard, J. A.; Lusis, A. J.; Cox, J. E.; Shaikh, S. R.; Tontonoz, P.; Funai, K.
Show abstract
Aberrant lipid metabolism promotes the development of skeletal muscle insulin resistance, but the exact identity of lipid-mediated mechanisms relevant to human obesity remains unclear. A comprehensive lipidomic analyses of primary myocytes from lean insulin-sensitive (LN) and obese insulin-resistant (OB) individuals revealed several species of lysophospholipids (lyso-PL) that were differentially-abundant. These changes coincided with greater expression of lysophosphatidylcholine acyltransferase 3 (LPCAT3), an enzyme involved in phospholipid transacylation (Lands cycle). Strikingly, mice with skeletal muscle-specific knockout of LPCAT3 (LPCAT3-MKO) exhibited greater muscle lyso-PC/PC, concomitant with greater insulin sensitivity in vivo and insulin-stimulated skeletal muscle glucose uptake ex vivo. Absence of LPCAT3 reduced phospholipid packing of the cellular membranes and increased plasma membrane lipid clustering, suggesting that LPCAT3 affects insulin receptor phosphorylation by modulating plasma membrane lipid organization. In conclusion, obesity accelerates the skeletal muscle Lands cycle, whose consequence might induce the disruption of plasma membrane organization that suppresses muscle insulin action.
Matching journals
The top 6 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Microtubule-mediated GLUT4 trafficking is disrupted in insulin resistant skeletal muscle 97%
- Loss of CTRP10 results in female obesity with preserved metabolic health 96%
- Identification of a weight loss-associated causal eQTL in MTIF3 and the effects of MTIF3 deficiency on human adipocyte function 96%
Similar papers in this journal
- Liver-specific suppression of ANGPTL4 improves obesity-associated diabetes and mitigates atherosclerosis in mice 95%
- Fatty Acid Transport Protein-2 (FATP2) Inhibition Enhances Glucose Tolerance through α-Cell-mediated GLP-1 Secretion 95%
- Inhibition of the Eukaryotic Initiation Factor-2-α Kinase PERK Decreases Risk of Autoimmune Diabetes in Mice 95%
Similar papers in this journal
- Perilipin2 down-regulation in beta cells impairs insulin secretion under nutritional stress and damages mitochondria 96%
- Fiber-type vulnerability and proteostasis reprogramming in skeletal muscle during pancreatic cancer cachexia 95%
- Thrombospondin-1 promotes fibro-adipogenic stromal expansion and contractile dysfunction of the diaphragm in obesity 95%
Similar papers in this journal
- Loss of Carnitine Palmitoyltransferase 1a Reduces Docosahexaenoic Acid-Containing Phospholipids and Drives Sexually Dimorphic Liver Disease in Mice 96%
- Hepatic Mitochondrial Remodeling is Mechanistically Linked to Insulin Resistance in Nonalcoholic Fatty Liver Disease 96%
- Feeding desensitizes A1 adenosine receptors in adipose through FOXO1-mediated transcriptional regulation 96%
Similar papers in this journal
- TRAF6 integrates innate immune signals to regulate glucose homeostasis via Parkin-dependent and -independent mitophagy 96%
- Ras-dependent RAF-MAPK hyperactivation by pathogenic RIT1 is a therapeutic target in Noonan syndrome-associated cardiac hypertrophy 94%
- Transcriptional regulation of adipocyte lipolysis by IRF2BP2 94%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.